Artal Group’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-200,000
Closed -$80K 151
2022
Q4
$80K Hold
200,000
﹤0.01% 124
2022
Q3
$156K Hold
200,000
0.01% 128
2022
Q2
$576K Hold
200,000
0.03% 117
2022
Q1
$1.25M Hold
200,000
0.05% 118
2021
Q4
$2.23M Hold
200,000
0.06% 123
2021
Q3
$3.27M Hold
200,000
0.07% 119
2021
Q2
$3.71M Hold
200,000
0.08% 119
2021
Q1
$3.02M Buy
+200,000
New +$3.02M 0.05% 122